VALIDATED STABILITY-INDICATING UPLC ASSAY METHOD A ND DEGRADATION BEHAVIOR OF RALTEGRAVIR POTASSIUM

[1]  D. Breilh,et al.  A sensitive liquid chromatography coupled with mass spectrometry method for the intracellular and plasma quantification of raltegravir after solid‐phase extraction , 2011, The Journal of pharmacy and pharmacology.

[2]  C. Flexner,et al.  Simultaneous determination of raltegravir and raltegravir glucuronide in human plasma by liquid chromatography-tandem mass spectrometric method. , 2011, Journal of mass spectrometry : JMS.

[3]  V. Furlan,et al.  Quantification of raltegravir (MK0518) in human plasma by high-performance liquid chromatography with photodiode array detection. , 2010, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[4]  C. Solas,et al.  Validation of an Electrospray Ionization LC-MS/MS Method for Quantitative Analysis of Raltegravir, Etravirine, and 9 Other Antiretroviral Agents in Human Plasma Samples , 2009, Therapeutic drug monitoring.

[5]  F. Stanke-Labesque,et al.  Lack of specificity for the analysis of raltegravir using online sample clean-up liquid chromatography-electrospray tandem mass spectrometry. , 2009, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[6]  H. Rosing,et al.  Quantification of the HIV-integrase inhibitor raltegravir and detection of its main metabolite in human plasma, dried blood spots and peripheral blood mononuclear cell lysate by means of high-performance liquid chromatography tandem mass spectrometry. , 2009, Journal of pharmaceutical and biomedical analysis.

[7]  A. D’Avolio,et al.  An HPLC-PDA Method for the Simultaneous Quantification of the HIV Integrase Inhibitor Raltegravir, the New Nonnucleoside Reverse Transcriptase Inhibitor Etravirine, and 11 Other Antiretroviral Agents in the Plasma of HIV-Infected Patients , 2008, Therapeutic drug monitoring.

[8]  E. Acosta,et al.  A sensitive HPLC-MS-MS method for the determination of raltegravir in human plasma. , 2008, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[9]  A. Savarino.  A historical sketch of the discovery and development of HIV-1 integrase inhibitors , 2006, Expert opinion on investigational drugs.

[10]  J. Veuthey,et al.  Fast analysis in liquid chromatography using small particle size and high pressure. , 2006, Journal of separation science.

[11]  E. Woolf,et al.  Determination of an investigational HIV integrase inhibitor in human plasma using high performance liquid chromatography with tandem mass spectrometric detection. , 2005, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[12]  A. Kashuba,et al.  Quantifying the HIV-1 integrase inhibitor raltegravir in female genital tract secretions using high-performance liquid chromatography with ultraviolet detection. , 2010, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.